There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot due to a lack of demand.

The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the first.

The vaccine could represent a weapon for preventing Lyme, a bacterial infection carried by ticks that is diagnosed and ...

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical administration ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see pushback from the government following studies.

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency ...

Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...

An announcement from Pfizer means Lyme disease numbers could soon drop.